Prediction of efficacy and viral kinetics using COBAS TaqMan HCV "automated" during antiviral treatment of hepatitis C

成司, 豊田; 吉康, 狩野; 淳, 赤池; 卓味, 大村; 隆啓, 佐藤; 克, 山崎; 靖昭, 桑田; 智宏, 荒川; 茂之, 古谷; 和弘, 松山; 隆雄, 原田

doi:10.2957/kanzo.49.297

Kanzo

2008

DOI: 10.2957/kanzo.49.297

|View full text |Cite

Prediction of efficacy and viral kinetics using COBAS TaqMan HCV "automated" during antiviral treatment of hepatitis C

豊田成司¹,

狩野吉康²,

赤池淳³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2009

2010

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Response-guided therapy in Japanese chronic hepatitis C patients infected with genotype 1b and high viral load

紀朋¹,

海²,

麻紀子³

et al. 2009

Kanzo

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Prediction of efficacy and viral kinetics using COBAS TaqMan HCV "automated" during antiviral treatment of hepatitis C

Cited by 3 publications

References 31 publications

Response-guided therapy in Japanese chronic hepatitis C patients infected with genotype 1b and high viral load

Response-guided therapy in Japanese chronic hepatitis C patients infected with genotype 1b and high viral load

The efficacy of prolonging treatment with peginterferon alfa-2b and ribavirin to 72 weeks in chronic hepatitis C genotype 1 patients HCV RNA positive at week 8 but negative at week 12

Efficacy of 60 weeks treatment of pegylated interferon plus ribavirin in patients whose HCV RNA tuned negative by real-time PCR assay at 12 weeks

Contact Info

Product

Resources

About